Front Range Biosciences, Inc. — Form D/A

Front Range Biosciences, Inc. of LAFAYETTE, CO, a company, filed a Form D amendment with the SEC on 2017-03-03. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Other.

Offering

• Filed: 2017-03-03
• Form: D/A
• Accession: 0001689059-17-000001
• Industry: Other
• Exemptions: 06b
• Total offering: $1.5M
• Amount sold: $1.5M
• Remaining: $8K
• Investors: 26
• Date of first sale: 2016-05-16
• Revenue range: Decline to Disclose
• SEC file number: 021-274531

Issuer

• Name: Front Range Biosciences, Inc.
• CIK: 0001689059
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: 1724 MAJESTIC DR., LAFAYETTE, CO, 80026
• Phone: 617-320-8743

Officers, directors & promoters (16)

Other filings by this issuer (6)

More

• CIK 1689059 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search